Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy: A randomized, controlled trial

M. Boogaerts, D. J. Winston, E. J. Bow, G. Garber, A. C. Reboli, A. P. Schwarer, N. Novitzky, A. Boehme, E. Chwetzoff, K. De Beule, C. Arthur, K. Lechner, W. Linkesch, R. Waldner, A. Bosly, F. Crokaert, J. Maertens, J. Michaux, L. Noens, W. SchroyensA. Van Hoof, I. Fong, A. Keating, M. Laverdière, A. McGeer, S. Nantel, C. Rotstein, W. Schlech, F. Smaill, P. Cassassus, P. Fenaux, S. Francois, R. Herbrecht, N. Ifrah, J. Pris, C. Mounier, G. Nedellec, P. Oriol, C. Rieux, A. Stamatoullas, J. Vernant, B. Witz, H. Goldschmidt, M. Pfreundschuh, U. Schuler, S. Daenen, A. Dekker, M. Kramer, M. Van Marwijk Kooy, E. Blundell, D. Milligan, G. Morgenstern, A. Pagliuca, H. Prentice, S. Rule, S. Schey, E. Anaissie, P. Arnow, J. Blummer, M. Martin, M. Territo, J. Wingard, T. Burzykowski, G. Molenberghs, A. Cuijpers, I. Van Hoof, C. Vertommen

Résultat de recherche: Article › examen par les pairs

343 Citations (Scopus)

Empreinte numérique

Plonger dans les sujets de recherche 'Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy: A randomized, controlled trial'. Ensemble, ils forment une empreinte numérique unique.

Medicine & Life Sciences